CLOROTEKAL

This brand name is authorized in United States. It is also authorized in Croatia, Estonia, France.

Active ingredients

The drug CLOROTEKAL contains one active pharmaceutical ingredient (API):

1	Chloroprocaine UNII LT7Z1YW11H - CHLOROPROCAINE HYDROCHLORIDE
	Chloroprocaine is procaine in which one of the hydrogens ortho- to the carboxylic acid group is substituted by chlorine. Chloroprocaine, blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse and by reducing the rate of rise of the action potential. Chloroprocaine (like cocaine) has the advantage of constricting blood vessels which reduces bleeding, unlike other local anesthetics like lidocaine.
	Read more about Chloroprocaine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CLOROTEKAL Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01BA04	Chloroprocaine	N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BA Esters of aminobenzoic acid
Discover more medicines within N01BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1777440, 1777451
FR	Base de données publique des médicaments	69316926
HR	Agencija za lijekove i medicinske proizvode	HR-H-338339613, HR-H-438588675
US	FDA, National Drug Code	0264-7055